Sponsored Links
| Global Health Ventures Announces Interim Data From The European Clinical Trails Of X-Excite Vs. Viagra |
 |
 |
 |
| Medical News - Erectile Dysfunction | |||
|
Global Health Ventures Inc. (OTCBB:GHLV), a specialty pharmaceutical company, is pleased to announce the interim results of the clinical trials conducted in Europe under the EMEA guideline protocols for its lead therapeutic drug, X-Excite. Data analysis from a small number of patients showed the drug to meet the three Pharmacokinetics (PK) end points... Read more: Erectile Dysfunction / Premature Ejaculation News From Medical News Today
|